856 filings
8-K
CLDX
Celldex Therapeutics Inc.
1 Mar 24
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
4:10pm
424B5
CLDX
Celldex Therapeutics Inc.
1 Mar 24
Prospectus supplement for primary offering
4:09pm
424B5
CLDX
Celldex Therapeutics Inc.
28 Feb 24
Prospectus supplement for primary offering
4:10pm
424B5
CLDX
Celldex Therapeutics Inc.
26 Feb 24
Prospectus supplement for primary offering
8:18am
10-K
2023 FY
CLDX
Celldex Therapeutics Inc.
Annual report
26 Feb 24
7:05am
8-K
CLDX
Celldex Therapeutics Inc.
26 Feb 24
Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
7:01am
4
CLDX
Celldex Therapeutics Inc.
15 Feb 24
Celldex Therapeutics / Freddy A. Jimenez ownership change
4:05pm
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
Celldex Therapeutics / Point72 Asset Management ownership change
4:17pm
SC 13G
Kynam Capital Management, LP
14 Feb 24
Celldex Therapeutics / Kynam Capital Management ownership change
12:52pm
SC 13G
Eventide Asset Managment LLC
14 Feb 24
Celldex Therapeutics / EVENTIDE ASSET MANAGEMENT ownership change
11:48am
SC 13G/A
RTW Investments, LP
14 Feb 24
Celldex Therapeutics / RTW INVESTMENTS ownership change
7:38am
SC 13G/A
CLDX
Celldex Therapeutics Inc.
13 Feb 24
Celldex Therapeutics / VANGUARD ownership change
5:00pm
SC 13G
Polar Capital Holdings Plc
13 Feb 24
Celldex Therapeutics / Polar Capital ownership change
9:41am
SC 13G/A
FMR LLC
9 Feb 24
Celldex Therapeutics / FMR ownership change
8:50am
SC 13G/A
Wellington Management Group LLP
8 Feb 24
Celldex Therapeutics / WELLINGTON MANAGEMENT ownership change
10:11am
SC 13G/A
BLK
Blackrock Inc.
26 Jan 24
Celldex Therapeutics / BlackRock ownership change
5:25pm
4
Martin Samuel Bates
4 Jan 24
Celldex Therapeutics / Samuel Bates Martin ownership change
4:05pm
SC 13G
Point72 Asset Management, L.P.
20 Nov 23
Celldex Therapeutics / Point72 Asset Management ownership change
4:15pm
8-K
CLDX
Celldex Therapeutics Inc.
8 Nov 23
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
5:03pm
424B5
CLDX
Celldex Therapeutics Inc.
8 Nov 23
Prospectus supplement for primary offering
5:01pm